706 related articles for article (PubMed ID: 27779101)
41. Prognostic and therapeutic implications of extracellular matrix associated gene signature in renal clear cell carcinoma.
Ahluwalia P; Ahluwalia M; Mondal AK; Sahajpal N; Kota V; Rojiani MV; Rojiani AM; Kolhe R
Sci Rep; 2021 Apr; 11(1):7561. PubMed ID: 33828127
[TBL] [Abstract][Full Text] [Related]
42. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
[TBL] [Abstract][Full Text] [Related]
43. Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.
Serie DJ; Joseph RW; Cheville JC; Ho TH; Parasramka M; Hilton T; Thompson RH; Leibovich BC; Parker AS; Eckel-Passow JE
Eur Urol; 2017 Jun; 71(6):979-985. PubMed ID: 27899233
[TBL] [Abstract][Full Text] [Related]
44. Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.
Gong X; Siprashvili Z; Eminaga O; Shen Z; Sato Y; Kume H; Homma Y; Ogawa S; Khavari PA; Pollack JR; Brooks JD
Oncotarget; 2017 Mar; 8(12):18657-18669. PubMed ID: 28423633
[TBL] [Abstract][Full Text] [Related]
45. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
Bao Z; Zhang W; Dong D
Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759
[TBL] [Abstract][Full Text] [Related]
46. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
He Z; Deng T; Duan X; Zeng G
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
[TBL] [Abstract][Full Text] [Related]
47. HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration.
Zhang F; Yuan D; Song J; Chen W; Wang W; Zhu G; Hu B; Chen X; Zhu J
Int Immunopharmacol; 2021 Oct; 99():107899. PubMed ID: 34217993
[TBL] [Abstract][Full Text] [Related]
48. Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma.
Xie H; Zhu Y; An H; Wang H; Zhu Y; Fu H; Wang Z; Fu Q; Xu J; Ye D
Oncotarget; 2016 May; 7(22):32723-30. PubMed ID: 27092876
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
[TBL] [Abstract][Full Text] [Related]
50. Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell Carcinoma.
Mehra R; Nallandhighal S; Cotta B; Knuth Z; Su F; Kasputis A; Zhang Y; Wang R; Cao X; Udager AM; Dhanasekaran SM; Cieslik MP; Morgan TM; Salami SS
JCO Precis Oncol; 2024 May; 8():e2300565. PubMed ID: 38810179
[TBL] [Abstract][Full Text] [Related]
51. High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma.
Lee C; Park JW; Suh JH; Moon KC
Pathol Res Pract; 2015 Nov; 211(11):824-8. PubMed ID: 26296917
[TBL] [Abstract][Full Text] [Related]
52. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
[TBL] [Abstract][Full Text] [Related]
53. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
[TBL] [Abstract][Full Text] [Related]
54. miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression.
Ma Q; Peng Z; Wang L; Li Y; Wang K; Zheng J; Liang Z; Liu T
Int J Oncol; 2016 Dec; 49(6):2589-2599. PubMed ID: 27779660
[TBL] [Abstract][Full Text] [Related]
55. A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma.
Chen S; Zhang E; Guo T; Shao J; Wang T; Zhang N; Wang X; Zheng J
BMC Cancer; 2022 Jan; 22(1):1. PubMed ID: 34979993
[TBL] [Abstract][Full Text] [Related]
56. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
[TBL] [Abstract][Full Text] [Related]
57. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
58. Development and verification of a nomogram for prediction of recurrence-free survival in clear cell renal cell carcinoma.
Chen Y; Jiang S; Lu Z; Xue D; Xia L; Lu J; Wang H; Xu L; Li L; Li G
J Cell Mol Med; 2020 Jan; 24(2):1245-1255. PubMed ID: 31782902
[TBL] [Abstract][Full Text] [Related]
59. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma.
Park JH; Lee C; Suh JH; Chae JY; Kim HW; Moon KC
Hum Pathol; 2015 Mar; 46(3):454-60. PubMed ID: 25628030
[TBL] [Abstract][Full Text] [Related]
60. Development of prognostic signature based on RNA binding proteins related genes analysis in clear cell renal cell carcinoma.
Chen Q; Li ZL; Fu SQ; Wang SY; Liu YT; Ma M; Yang XR; Xie WJ; Gong BB; Sun T
Aging (Albany NY); 2021 Jan; 13(3):3926-3944. PubMed ID: 33461173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
